<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="2020. Together with the other two highly pathogenic coronaviruses, the" exact="severe acute respiratory syndrome" post="coronavirus (SARS‐CoV) and Middle East respiratory syndrome coronavirus (MERS‐CoV),"/>
 <result pre="1 INTRODUCTION In late December 2019, clusters of patients with" exact="pneumonia" post="of unknown etiology were reported by the local health"/>
 <result pre="1 In early January 2020, the causative agent of mysterious" exact="pneumonia" post="has been identified as a novel coronavirus by several"/>
 <result pre="seen outbreaks caused by two other highly pathogenic coronaviruses, the" exact="severe acute respiratory syndrome" post="coronavirus (SARS‐CoV) and the Middle East respiratory syndrome coronavirus"/>
 <result pre="presentations, which can vary from asymptomatic infection to severe disease;" exact="severe acute respiratory syndrome." post="5 , 6 Therefore, our current knowledge of the"/>
 <result pre="MERS‐CoV infection include exudative diffuse alveolar damage with hyaline membranes," exact="pulmonary edema," post="type II pneumocyte hyperplasia, interstitial pneumonia (which was predominantly"/>
 <result pre="with hyaline membranes, pulmonary edema, type II pneumocyte hyperplasia, interstitial" exact="pneumonia" post="(which was predominantly lymphocytic), and multinucleate syncytial cells. 22"/>
 <result pre="22 These bronchial lesions comprise the pathologic basis for the" exact="respiratory failure" post="and radiologic abnormalities of MERS‐CoV infection. 24 Target cells"/>
 <result pre="ultrastructural findings in the kidney, renal biopsies demonstrated acute tubulointerstitial" exact="nephritis" post="and acute tubular sclerosis with proteinaceous cast formation. 26"/>
 <result pre="also developed dyspnea and lymphopenia. Complications of 2019‐nCoV infections included" exact="acute respiratory distress syndrome," post="RNAaemia, acute cardiac injury, and secondary (super‐)infections. 38 All"/>
 <result pre="for Viral Immunology. References REFERENCES 1 http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. Report of clustering" exact="pneumonia" post="of unknown etiology in Wuhan City. 2019. 2 Chen"/>
 <result pre="W , et al. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med. 2020 10.1056/NEJMoa2001017"/>
 <result pre=", Kok KH , et al. A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person‐to‐person transmission:"/>
 <result pre=", Lee KC , et al. Lung pathology of fatal" exact="severe acute respiratory syndrome." post="Lancet. 2003; 361( 9371): 1773‐ 1778. 12781536 8 Ding"/>
 <result pre=", Shen H , et al. The clinical pathology of" exact="severe acute respiratory syndrome" post="(SARS): a report from China . J Pathol. 2003;"/>
 <result pre="Bradley BT , Bryan A . Emerging respiratory infections: The" exact="infectious disease" post="pathology of SARS, MERS, pandemic influenza, and Legionella ."/>
 <result pre="of SARS‐associated coronavirus in lung of a fatal case of" exact="severe acute respiratory syndrome" post="in Taiwan . Hum Pathol. 2005; 36( 3): 303‐"/>
 <result pre="AKL , et al. Plasma inflammatory cytokines and chemokines in" exact="severe acute respiratory syndrome." post="Clin Exp Immunol. 2004; 136( 1): 95‐ 103. 15030519"/>
 <result pre="B , Salto‐Tellez M . Elucidating the molecular physiopathology of" exact="acute respiratory distress syndrome" post="in severe acute respiratory syndrome patients . Virus Res."/>
 <result pre="Elucidating the molecular physiopathology of acute respiratory distress syndrome in" exact="severe acute respiratory syndrome" post="patients . Virus Res. 2009; 145( 2): 260‐ 269."/>
 <result pre=". Temporal changes in cytokine/chemokine profiles and pulmonary involvement in" exact="severe acute respiratory syndrome" post=". Respirology. 2006; 11( 6): 715‐ 722. 17052299 18"/>
 <result pre=", et al. Analysis of serum cytokines in patients with" exact="severe acute respiratory syndrome." post="Infect Immun. 2004; 72( 8): 4410‐ 4415. 15271897 19"/>
 <result pre="with atypical innate and adaptive immune responses in patients with" exact="severe acute respiratory syndrome" post=". J Virol. 2007; 81( 16): 8692‐ 8706. 17537853"/>
 <result pre=", Eisfeld AJ , Schäfer A , et al. Pathogenic" exact="influenza" post="viruses and coronaviruses utilize similar and contrasting approaches to"/>
 <result pre="Dysregulated type I interferon and inflammatory monocyte‐macrophage responses cause lethal" exact="pneumonia" post="in SARS‐CoV‐infected mice . Cell Host Microbe. 2016; 19("/>
 <result pre=", et al. Identification of a novel coronavirus causing severe" exact="pneumonia" post="in human: a descriptive study . Chin Med J."/>
 <result pre="Zhou P , Yang XL , Wang XG . A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study . Lancet. 2020;"/>
</results>
